700 patients110,866 observations180 daysLIVE

Patient P-02298

Synthetic patientMETA-24 · Day 90 · 75+ · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S14
  2. Day 66 SC-12 recommendedSupportive Compound SC-12
  3. Day 67 Patient declinedNot now
  4. Day 77 GI-04 recommendedGI Support Protocol GI-04
  5. Day 78 Patient acceptedStarted GI-04 in the companion
  6. Day 86 GI symptom burden −32% vs expectedGI Support Protocol GI-04
  7. Day 92 Tolerance state changedUnstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity+7
  • Treatment adherence+5
  • GI instability+4
  • Nutritional resilience+2

What helped?

  • Supportive Compound SC-12Day 66
    Declined by patient
  • GI Support Protocol GI-04Day 77
    Result: symptom burden −32%
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
51%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 75% showed improvement
  • median effect visible after 5 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
53 min
improving · +3.8 vs previous 14 d
Sleep duration
Wearable
7.6 h
stable · +0.2 vs previous 14 d
Energy level
Daily log
5.5/10
stable · -0.1 vs previous 14 d
Steps
Wearable
5,411
improving · +410 vs previous 14 d
GI burden
Companion
40.2/100
worsening · +3.6 vs previous 14 d
Adherence
Companion
93.3 %
stable · -1.4 vs previous 14 d
Sleep quality
Wearable
52/100
stable · -1.5 vs previous 14 d
Glucose, CGM daily mean
CGM
125 mg/dL
stable · +2.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 59 from the failing basin, 29 from restoration.

Would help
  • DT-01 Dosing / Timing Recommendation
    75% improved among 8 similar · onset 5 d · confidence 52%
  • HY-01 Hydration Protocol
    63% improved among 8 similar · onset 4 d · confidence 52%
  • More protein
    GI -4 next day on high-intake days · n 19
Would not help
  • Keep histamine low
    GI +4.8 next day on high-intake days · n 20
  • Keep fat low
    GI +4 next day on high-intake days · n 22
  • Keep ultra-processed low
    GI +3.7 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Histamine load
    +4.8detractor · 95%
  • Dietary fat load
    +4detractor · 95%
  • Protein
    -4supporter · 95%
  • Ultra-processed food
    +3.7detractor · 95%
  • Simple carbohydrates
    +2.5detractor · 79%
  • Caffeine
    -1.8no signal · 51%
  • Alcohol
    -1.1no signal · 27%
  • Insoluble fibre
    +1no signal · 21%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 32/100
    • MicrobiomeF. prausnitzii depleted
  • Mucosal barrier integrity 30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Normal metabolizer
    Expected exposure
  • GLP1R rs6923761 A
    Altered receptor sensitivity
Microbiome
Shannon diversity 1.9 · butyrate capacity 32/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
57 ms
Sleep
7.7 h
Steps
5,929
Resting HR
61 bpm
Daily log: GI score 40, nutritional resilience 53, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0243734%S0164
P-0221733%S0161
P-0227633%S0157
P-0255033%S0170
P-0230732%S0155
P-0259832%S0153
P-0262032%S01HY-01improved64
P-0213831%S0179
P-0220431%S0170
P-0227531%S0184
P-0259231%S0174
P-0268131%S0151